EAU-ESTRO course: Multidisciplinary Management of Prostate Cancer
This 4-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It will take place from 26 October 2025 to 30 October 2025 in Verona, Italy.
This course emphasises the importance of a multidisciplinary approach and of teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based. This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiotherapists will also be organised during the course.
| Organiser | ESTRO |
|---|---|
| CME | Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician's Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office. |
| Venue | Crowne Plaza Verona – Fiera |
| Address | Via Belgio16 37135 Verona VR Italy, Verona, Italy |
The course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge.
Learning outcomes
- To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high-risk prostate cancer
- To discuss patient selection/indications and contraindications for the various treatment options
- To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer
- To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease
- To debate the most recent developments relevant to prostate cancer management.
Course content
- Normal prostate: anatomy, embryology, histology
- Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities, pathology, staging
- Prostate cancer management according to risk groups: active surveillance, surgery, radiotherapy
- External beam radiotherapy: online control, target delineation
- Toxicity of radiotherapy: acute and late morbidity, erectile dysfunction
- Role of surgery and its morbidity
- Alternative treatments
- Adjuvant and salvage radiotherapy after radical surgery
- Rising PSA after surgery and after radiotherapy
- Imaging for recurrent detection
- Node-positive prostate cancer
- Hormone-sensitive metastatic prostate cancer
- Castration resistant prostate cancer
- Palliative radiotherapy and surgery
- Non-systemic treatment in the metastatic setting.
- Case discussions